» Articles » PMID: 30755654

NKT Cells in Mice Originate from Cytoplasmic CD3-Positive, CD4CD8 Double-Negative Thymocytes That Express CD44 and IL-7Rα

Overview
Journal Sci Rep
Specialty Science
Date 2019 Feb 14
PMID 30755654
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Although natural killer T cells (NKT cells) are thought to be generated from CD4CD8 (DP) thymocytes, the developmental origin of CD4CD8 (DN) NKT cells has remained unclear. In this study, we found the level of NK1.1 expression was highest in DN cells, followed by CD4 and CD8 (SP) and DP cells. The level of NK1.1 expression was highest in CD44CD25 (DN) cells, after that CD44CD25 (DN), finally, CD44CD25 (DN) and CD44 CD25 (DN) cells. Unexpectedly, cytoplasmic CD3 was not only expressed in SP and DP thymocytes but also in most DN thymocytes at various stages. The mean fluorescence of cytoplasmic and surface CD3 in DN cells was significantly lower than in mature (SP) T and NKT cells in the thymus and spleen. Interestingly, there were more NKT cells in DN-cytoplasmic CD3 expression cells was higher than in DN-surface CD3 expression cells. There were more CD3-NKT cells in DN thymocytes than in TCR-β-NKT cells. NKT cells expressed higher levels of IL-7Rα which was correlated with CD44 expression in the thymus. Our data suggest that T cells and NKT cells follow similar patterns of expression with respect to cytoplasmic and surface CD3. Cytoplasmic CD3 could be used as a marker for early stage T cells. Both cytoplasmic CD3 and surface CD3 were expressed in mature T cells and immature T cells, including the immature cytoplasmic CD3 surface CD3 and surface CD3TCR-β cells in DN-NKT thymocytes. CD44 could be used as an additional marker of NKT cells which may originate from cytoplasmic CD3-positive DN thymocytes that express CD44 and IL-7Rα in mice.

Citing Articles

Ruxolitinib and oHSV combination therapy increases CD4 T cell activity and germinal center B cell populations in murine sarcoma.

Dhital R, Kim Y, Kim D, Hernandez-Aguirre I, Hedberg J, Martin A Mol Ther Oncol. 2025; 33(1):200929.

PMID: 39895689 PMC: 11787636. DOI: 10.1016/j.omton.2024.200929.


Oncolytic cytomegaloviruses expressing EGFR-retargeted fusogenic glycoprotein complex and drug-controllable interleukin 12.

Jiang H, Nace R, Ferguson C, Zhang L, Peng K, Russell S Cell Rep Med. 2024; 6(1):101874.

PMID: 39694038 PMC: 11866437. DOI: 10.1016/j.xcrm.2024.101874.


Racing CARs to veterinary immuno-oncology.

Cockey J, Leifer C Front Vet Sci. 2023; 10:1130182.

PMID: 36876006 PMC: 9982037. DOI: 10.3389/fvets.2023.1130182.


The impact of the gut microbiota on T cell ontogeny in the thymus.

Hebbandi Nanjundappa R, Umeshappa C, Geuking M Cell Mol Life Sci. 2022; 79(4):221.

PMID: 35377005 PMC: 11072498. DOI: 10.1007/s00018-022-04252-y.

References
1.
Sato H, Nakayama T, Tanaka Y, Yamashita M, Shibata Y, Kondo E . Induction of differentiation of pre-NKT cells to mature Valpha14 NKT cells by granulocyte/macrophage colony-stimulating factor. Proc Natl Acad Sci U S A. 1999; 96(13):7439-44. PMC: 22104. DOI: 10.1073/pnas.96.13.7439. View

2.
Wilson A, Capone M, MacDonald H . Unexpectedly late expression of intracellular CD3epsilon and TCR gammadelta proteins during adult thymus development. Int Immunol. 1999; 11(10):1641-50. DOI: 10.1093/intimm/11.10.1641. View

3.
Coles M, Raulet D . NK1.1+ T cells in the liver arise in the thymus and are selected by interactions with class I molecules on CD4+CD8+ cells. J Immunol. 2000; 164(5):2412-8. DOI: 10.4049/jimmunol.164.5.2412. View

4.
Kane L, Lin J, Weiss A . Signal transduction by the TCR for antigen. Curr Opin Immunol. 2000; 12(3):242-9. DOI: 10.1016/s0952-7915(00)00083-2. View

5.
Nandi A, Estess P, SIEGELMAN M . Hyaluronan anchoring and regulation on the surface of vascular endothelial cells is mediated through the functionally active form of CD44. J Biol Chem. 2000; 275(20):14939-48. DOI: 10.1074/jbc.275.20.14939. View